Cyklokapron, Lysteda, Tranexamic Acid (tranexamic acid) is a small molecule pharmaceutical. Tranexamic acid was first approved as Cyklokapron on 1986-12-30. It is used to treat inherited blood coagulation disorders and subarachnoid hemorrhage in the USA. The pharmaceutical is active against plasminogen. Cyklokapron's patent is valid until 2025-03-04 (FDA).
|Trade Name||Cyklokapron, Lysteda, Tranexamic Acid|
|Common Name||Tranexamic acid|
|Indication||inherited blood coagulation disorders, subarachnoid hemorrhage|